Meetings - The ASCO Post

Women aged 75 years and older may benefit from continued screening mammograms because of the comparatively high incidence of breast cancer found in this age group, according to a study presented at th...

breast cancer

By The ASCO Post Staff / RSNA 2018

RSNA 2018: Breast Cancer Risk-Based Mammography Screening in Younger Women

A new, large-scale study of more than 5 million mammograms found that annual mammography screening beginning at age 30 may benefit women with at least 1 of 3 specific risk factors: dense breasts, a pe...

breast cancer

By The ASCO Post Staff / RSNA 2018

RSNA 2018: Preliminary Results of Primary Cryoablation in Treating Low-Risk Breast Cancers

Cryoablation has shown early indications of effectiveness in treating women with low-risk breast cancers, according to research presented at the Annual Meeting of the Radiological Society of North Ame...

RSNA 2018

RSNA 2018: Mammography Screening Beyond Age 75

RSNA 2018: Breast Cancer Risk-Based Mammography Screening in Younger Women

RSNA 2018: Preliminary Results of Primary Cryoablation in Treating Low-Risk Breast Cancers

FDA Approves Datopotamab Deruxtecan-dlnk for Advanced HR-Positive, HER2-Negative Breast Cancer

FDA Approves Sotorasib With Panitumumab for KRAS G12C–Mutated Colorectal Cancer

Fulvestrant vs Anastrozole in Endocrine Therapy–Naive, HR-Positive, HER2-Negative Advanced Breast Cancer

AACR Expresses Sincere Appreciation After NIH Director Monica M Bertagnolli MD Steps Down

FDA Approves Acalabrutinib With Bendamustine and Rituximab for Previously Untreated Mantle Cell Lymphoma